The Lead Episode 54: Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants-The Lead Episode 54 Speaker Information

The Lead Episode 54 Speaker Information

Pdf Summary

The discussion highlighted the development and validation of the DOAC Score, a new tool for predicting bleeding risk in atrial fibrillation patients on direct-acting oral anticoagulants. The article, authored by a team including Rahul Aggarwal, Christian T. Ruﬀ, and others, was published in the journal Circulation. Hosted by Deepthy Varghese from Northside Hospital, contributors Gregory Lip from the University of Liverpool and Elaine Y. Wan from Columbia University provided insights. Gregory Lip disclosed relationships with Bristol-Myers Squibb and Pfizer, while Elaine Y. Wan had connections with Medtronic, NIH, and others. Deepthy Varghese had no disclosures. The DOAC Score offers a promising approach to assessing bleeding risk in this patient population, providing valuable information for clinicians managing atrial fibrillation.

Keywords

DOAC Score

bleeding risk

atrial fibrillation

direct-acting oral anticoagulants

Rahul Aggarwal

Christian T. Ruﬀ

Circulation journal

Deepthy Varghese

Gregory Lip

Elaine Y. Wan